FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Urinary tract cancer prediction models with high sensitivity and specificity

2.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

3.

Prostate cancer screening program beneficial in top decile of polygenic risk score

4.

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.

5.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot